世界の二重特異性抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bi-Specific Antibodies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5623
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、89ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、二重特異性抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フラグメントベース抗体、IgGベース抗体）、用途別市場規模（がん、血友病、その他非がん性疾患）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・二重特異性抗体の市場動向
・企業の競争状況、市場シェア
・二重特異性抗体の種類別市場規模と予測2016-2027（フラグメントベース抗体、IgGベース抗体）
・二重特異性抗体の用途別市場規模と予測2016-2027（がん、血友病、その他非がん性疾患）
・二重特異性抗体の北米市場規模2016-2027（アメリカ、カナダ）
・二重特異性抗体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・二重特異性抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・二重特異性抗体の中南米市場規模2016-2027（メキシコ、ブラジル）
・二重特異性抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche (Chugai)、Amgen）
・結論

A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.

Market Analysis and Insights: Global Bi-Specific Antibodies Market
The global Bi-Specific Antibodies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bi-Specific Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bi-Specific Antibodies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bi-Specific Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bi-Specific Antibodies market.

Global Bi-Specific Antibodies Scope and Market Size
Bi-Specific Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bi-Specific Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Fragment-Based Antibodies
IgG-Based Antibodies

Segment by Application
Cancer
Haemophilia
Other Non-Cancer Diseases

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche (Chugai)
Amgen

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bi-Specific Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fragment-Based Antibodies
1.2.3 IgG-Based Antibodies
1.3 Market by Application
1.3.1 Global Bi-Specific Antibodies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Other Non-Cancer Diseases
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bi-Specific Antibodies Market Perspective (2016-2027)
2.2 Bi-Specific Antibodies Growth Trends by Regions
2.2.1 Bi-Specific Antibodies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bi-Specific Antibodies Historic Market Share by Regions (2016-2021)
2.2.3 Bi-Specific Antibodies Forecasted Market Size by Regions (2022-2027)
2.3 Bi-Specific Antibodies Industry Dynamic
2.3.1 Bi-Specific Antibodies Market Trends
2.3.2 Bi-Specific Antibodies Market Drivers
2.3.3 Bi-Specific Antibodies Market Challenges
2.3.4 Bi-Specific Antibodies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bi-Specific Antibodies Players by Revenue
3.1.1 Global Top Bi-Specific Antibodies Players by Revenue (2016-2021)
3.1.2 Global Bi-Specific Antibodies Revenue Market Share by Players (2016-2021)
3.2 Global Bi-Specific Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bi-Specific Antibodies Revenue
3.4 Global Bi-Specific Antibodies Market Concentration Ratio
3.4.1 Global Bi-Specific Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific Antibodies Revenue in 2020
3.5 Bi-Specific Antibodies Key Players Head office and Area Served
3.6 Key Players Bi-Specific Antibodies Product Solution and Service
3.7 Date of Enter into Bi-Specific Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bi-Specific Antibodies Breakdown Data by Type
4.1 Global Bi-Specific Antibodies Historic Market Size by Type (2016-2021)
4.2 Global Bi-Specific Antibodies Forecasted Market Size by Type (2022-2027)

5 Bi-Specific Antibodies Breakdown Data by Application
5.1 Global Bi-Specific Antibodies Historic Market Size by Application (2016-2021)
5.2 Global Bi-Specific Antibodies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bi-Specific Antibodies Market Size (2016-2027)
6.2 North America Bi-Specific Antibodies Market Size by Type
6.2.1 North America Bi-Specific Antibodies Market Size by Type (2016-2021)
6.2.2 North America Bi-Specific Antibodies Market Size by Type (2022-2027)
6.2.3 North America Bi-Specific Antibodies Market Size by Type (2016-2027)
6.3 North America Bi-Specific Antibodies Market Size by Application
6.3.1 North America Bi-Specific Antibodies Market Size by Application (2016-2021)
6.3.2 North America Bi-Specific Antibodies Market Size by Application (2022-2027)
6.3.3 North America Bi-Specific Antibodies Market Size by Application (2016-2027)
6.4 North America Bi-Specific Antibodies Market Size by Country
6.4.1 North America Bi-Specific Antibodies Market Size by Country (2016-2021)
6.4.2 North America Bi-Specific Antibodies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bi-Specific Antibodies Market Size (2016-2027)
7.2 Europe Bi-Specific Antibodies Market Size by Type
7.2.1 Europe Bi-Specific Antibodies Market Size by Type (2016-2021)
7.2.2 Europe Bi-Specific Antibodies Market Size by Type (2022-2027)
7.2.3 Europe Bi-Specific Antibodies Market Size by Type (2016-2027)
7.3 Europe Bi-Specific Antibodies Market Size by Application
7.3.1 Europe Bi-Specific Antibodies Market Size by Application (2016-2021)
7.3.2 Europe Bi-Specific Antibodies Market Size by Application (2022-2027)
7.3.3 Europe Bi-Specific Antibodies Market Size by Application (2016-2027)
7.4 Europe Bi-Specific Antibodies Market Size by Country
7.4.1 Europe Bi-Specific Antibodies Market Size by Country (2016-2021)
7.4.2 Europe Bi-Specific Antibodies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bi-Specific Antibodies Market Size (2016-2027)
8.2 Asia-Pacific Bi-Specific Antibodies Market Size by Type
8.2.1 Asia-Pacific Bi-Specific Antibodies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bi-Specific Antibodies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bi-Specific Antibodies Market Size by Type (2016-2027)
8.3 Asia-Pacific Bi-Specific Antibodies Market Size by Application
8.3.1 Asia-Pacific Bi-Specific Antibodies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bi-Specific Antibodies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bi-Specific Antibodies Market Size by Application (2016-2027)
8.4 Asia-Pacific Bi-Specific Antibodies Market Size by Region
8.4.1 Asia-Pacific Bi-Specific Antibodies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bi-Specific Antibodies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bi-Specific Antibodies Market Size (2016-2027)
9.2 Latin America Bi-Specific Antibodies Market Size by Type
9.2.1 Latin America Bi-Specific Antibodies Market Size by Type (2016-2021)
9.2.2 Latin America Bi-Specific Antibodies Market Size by Type (2022-2027)
9.2.3 Latin America Bi-Specific Antibodies Market Size by Type (2016-2027)
9.3 Latin America Bi-Specific Antibodies Market Size by Application
9.3.1 Latin America Bi-Specific Antibodies Market Size by Application (2016-2021)
9.3.2 Latin America Bi-Specific Antibodies Market Size by Application (2022-2027)
9.3.3 Latin America Bi-Specific Antibodies Market Size by Application (2016-2027)
9.4 Latin America Bi-Specific Antibodies Market Size by Country
9.4.1 Latin America Bi-Specific Antibodies Market Size by Country (2016-2021)
9.4.2 Latin America Bi-Specific Antibodies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bi-Specific Antibodies Market Size (2016-2027)
10.2 Middle East & Africa Bi-Specific Antibodies Market Size by Type
10.2.1 Middle East & Africa Bi-Specific Antibodies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bi-Specific Antibodies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bi-Specific Antibodies Market Size by Type (2016-2027)
10.3 Middle East & Africa Bi-Specific Antibodies Market Size by Application
10.3.1 Middle East & Africa Bi-Specific Antibodies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bi-Specific Antibodies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bi-Specific Antibodies Market Size by Application (2016-2027)
10.4 Middle East & Africa Bi-Specific Antibodies Market Size by Country
10.4.1 Middle East & Africa Bi-Specific Antibodies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bi-Specific Antibodies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche (Chugai)
11.1.1 Roche (Chugai) Company Details
11.1.2 Roche (Chugai) Business Overview
11.1.3 Roche (Chugai) Bi-Specific Antibodies Introduction
11.1.4 Roche (Chugai) Revenue in Bi-Specific Antibodies Business (2016-2021)
11.1.5 Roche (Chugai) Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Bi-Specific Antibodies Introduction
11.2.4 Amgen Revenue in Bi-Specific Antibodies Business (2016-2021)
11.2.5 Amgen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bi-Specific Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fragment-Based Antibodies
Table 3. Key Players of IgG-Based Antibodies
Table 4. Global Bi-Specific Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Bi-Specific Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bi-Specific Antibodies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Bi-Specific Antibodies Market Share by Regions (2016-2021)
Table 8. Global Bi-Specific Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Bi-Specific Antibodies Market Share by Regions (2022-2027)
Table 10. Bi-Specific Antibodies Market Trends
Table 11. Bi-Specific Antibodies Market Drivers
Table 12. Bi-Specific Antibodies Market Challenges
Table 13. Bi-Specific Antibodies Market Restraints
Table 14. Global Bi-Specific Antibodies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Bi-Specific Antibodies Market Share by Players (2016-2021)
Table 16. Global Top Bi-Specific Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bi-Specific Antibodies as of 2020)
Table 17. Ranking of Global Top Bi-Specific Antibodies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Bi-Specific Antibodies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bi-Specific Antibodies Product Solution and Service
Table 21. Date of Enter into Bi-Specific Antibodies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bi-Specific Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Bi-Specific Antibodies Revenue Market Share by Type (2016-2021)
Table 25. Global Bi-Specific Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Bi-Specific Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Bi-Specific Antibodies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Bi-Specific Antibodies Revenue Market Share by Application (2016-2021)
Table 29. Global Bi-Specific Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Bi-Specific Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Bi-Specific Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Bi-Specific Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Bi-Specific Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Bi-Specific Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Bi-Specific Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Bi-Specific Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Bi-Specific Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Bi-Specific Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Bi-Specific Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Bi-Specific Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Bi-Specific Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Bi-Specific Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Bi-Specific Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Bi-Specific Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bi-Specific Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bi-Specific Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bi-Specific Antibodies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Bi-Specific Antibodies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Bi-Specific Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Bi-Specific Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Bi-Specific Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Bi-Specific Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Bi-Specific Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Bi-Specific Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Bi-Specific Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Bi-Specific Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bi-Specific Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bi-Specific Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bi-Specific Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Bi-Specific Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche (Chugai) Company Details
Table 62. Roche (Chugai) Business Overview
Table 63. Roche (Chugai) Bi-Specific Antibodies Product
Table 64. Roche (Chugai) Revenue in Bi-Specific Antibodies Business (2016-2021) & (US$ Million)
Table 65. Roche (Chugai) Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Bi-Specific Antibodies Product
Table 69. Amgen Revenue in Bi-Specific Antibodies Business (2016-2021) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bi-Specific Antibodies Market Share by Type: 2020 VS 2027
Figure 2. Fragment-Based Antibodies Features
Figure 3. IgG-Based Antibodies Features
Figure 4. Global Bi-Specific Antibodies Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Haemophilia Case Studies
Figure 7. Other Non-Cancer Diseases Case Studies
Figure 8. Bi-Specific Antibodies Report Years Considered
Figure 9. Global Bi-Specific Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Bi-Specific Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Bi-Specific Antibodies Market Share by Regions: 2020 VS 2027
Figure 12. Global Bi-Specific Antibodies Market Share by Regions (2022-2027)
Figure 13. Global Bi-Specific Antibodies Market Share by Players in 2020
Figure 14. Global Top Bi-Specific Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bi-Specific Antibodies as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Bi-Specific Antibodies Revenue in 2020
Figure 16. Global Bi-Specific Antibodies Revenue Market Share by Type (2016-2021)
Figure 17. Global Bi-Specific Antibodies Revenue Market Share by Type (2022-2027)
Figure 18. North America Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Bi-Specific Antibodies Market Share by Type (2016-2027)
Figure 20. North America Bi-Specific Antibodies Market Share by Application (2016-2027)
Figure 21. North America Bi-Specific Antibodies Market Share by Country (2016-2027)
Figure 22. United States Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bi-Specific Antibodies Market Share by Type (2016-2027)
Figure 26. Europe Bi-Specific Antibodies Market Share by Application (2016-2027)
Figure 27. Europe Bi-Specific Antibodies Market Share by Country (2016-2027)
Figure 28. Germany Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bi-Specific Antibodies Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Bi-Specific Antibodies Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Bi-Specific Antibodies Market Share by Region (2016-2027)
Figure 38. China Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bi-Specific Antibodies Market Share by Type (2016-2027)
Figure 46. Latin America Bi-Specific Antibodies Market Share by Application (2016-2027)
Figure 47. Latin America Bi-Specific Antibodies Market Share by Country (2016-2027)
Figure 48. Mexico Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bi-Specific Antibodies Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Bi-Specific Antibodies Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Bi-Specific Antibodies Market Share by Country (2016-2027)
Figure 54. Turkey Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Bi-Specific Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Roche (Chugai) Revenue Growth Rate in Bi-Specific Antibodies Business (2016-2021)
Figure 58. Amgen Revenue Growth Rate in Bi-Specific Antibodies Business (2016-2021)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Global Bispecific Monoclonal Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-5624 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、二重特異性モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フラグメントベース抗体、IgGベース抗体）、用途別市場規模（がん、血友病、その他非がん性疾患）、主要地域別市場規模（北米、ア...

世界のナノ抗体市場規模・現状・予測（2021年-2027年）

Global Nano Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-5874 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、ナノ抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（一価ナノボディ、多価・多重特異性ナノボディ、融合ナノボディ）、用途別市場規模（in vitro疾患検出、in vivo非侵襲的診断、腫瘍標的療法...

世界の特定タンパク質検査市場規模・現状・予測（2021年-2027年）

Global Specific Protein Testing Market Size, Status and Forecast 2021-2027
QFJ1-4888 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、特定タンパク質検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポリポタンパク質C-II、アポリポタンパク質C-III、アポリポタンパク質E、その他）、用途別市場規模（病院、クリニック、診断研究所...

世界の関節炎モノクローナル抗体市場規模・現状・予測（2021年-2027年）

Global Arthritis Monoclonal Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-3853 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、関節炎モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（レミケード、ヒュミラ、エンブレル、リツキサン、オレンシア、アクテムラ、シンポニ、シムジア）、用途別市場規模（関節リウマチ、変形性...

世界の腫瘍特異抗原市場規模・現状・予測（2021年-2027年）

Global Tumor-Specific Antigen Market Size, Status and Forecast 2021-2027
QFJ1-4991 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、腫瘍特異抗原の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コーディング領域、ノンコーディング領域）、用途別市場規模（創薬、診断、臨床・基礎研究、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の前立腺特異抗原（PSA）バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Prostate Specific Antigen (PSA) Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4772 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、前立腺特異抗原（PSA）バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血、精液、尿）、用途別市場規模（診断、創薬、個別化医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のタンパク質＆抗体＆核酸デリバリー技術市場規模・現状・予測（2021年-2027年）

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Status and Forecast 2021-2027
QFJ1-4941 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、タンパク質＆抗体＆核酸デリバリー技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HEPtune®技術、Intravail®技術、RapidMist™、TheraKine技術、Arestat™技術、...

世界の前立腺特異抗原（PSA）血液ベースバイオマーカー市場規模・現状・予測（2021年-2027年）

Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4773 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、前立腺特異抗原（PSA）血液ベースバイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スクリーニングバイオマーカー、診断バイオマーカー）、用途別市場規模（診断、創薬、個別化医療、その他）、主...

世界の研究用抗体＆試薬市場規模・現状・予測（2021年-2027年）

Global Research Antibodies & Reagents Market Size, Status and Forecast 2021-2027
QFJ1-4813 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、研究用抗体＆試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ウエスタンブロッティング、蛍光抗体法、免疫吸着測定法、フローサイトメトリー、免疫組織化学、免疫沈降）、用途別市場規模（プロテオミクス、創...

世界の前立腺特異抗原（PSA）検査市場規模・現状・予測（2021年-2027年）

Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2021-2027
QFJ1-4774 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、前立腺特異抗原（PSA）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLIA法、ELISA法）、用途別市場規模（スクリーニング、治療後モニタリング、その他）、主要地域別市場規模（北米、アメリカ...

世界の二重特異性モノクローナル抗体市場規模・現状・予測（2021年-2027年） A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antig…
世界のナノ抗体市場規模・現状・予測（2021年-2027年） Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages: Small size (~15kd) High affinity (frequently nanomolar range) High specificity Unsurpa…
世界の関節炎モノクローナル抗体市場規模・現状・予測（2021年-2027年） Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory diseases Market Analysis and Insights: Global Arthritis Monoclonal Antibodies Market The global Arthritis Monoclonal Antibodies market size is project…
世界のタンパク質＆抗体＆核酸デリバリー技術市場規模・現状・予測（2021年-2027年） Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Given their high target specificity and limited toxicity compared to small molecule drugs, biotherapeutics have revolutionized treatment paradigms in a myriad of clinical conditions, including metabolic disorders, cancer, neur…
世界の研究用抗体＆試薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Research Antibodies & Reagents Market The global Research Antibodies & Reagents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…